Amarantus Bioscience Holdings Inc (AMBS)

[blackhawks]

No he said it is worth $42 million right now, or .19 PPS... not including the diagnostic platforms which have the potential for $800 million/year revenue in the medium-future. So by his analysis we are grossly undervalued right now.

But, is the analysis correct? By this point I wouldn't be surprised if the author himself isn't puzzled by the retreat in AMBS pps after his article appeared.

So far, then, the share price is not reacting as though the information is accurate or as though it is accepted. We have all of the potential new investors who read Seeking Alpha and of course we have the ihub investors who are mostly inclined to agree with at least the science in the first article and the recent article's short term outlook for AMBS.

The absence of positive impact on trading action following the article actually makes me apprehensive for the appearance of his valuation on the Diagnostic piece, not for any deficiency in the analysis but rather for a realistic estimate of time to market.